429 related articles for article (PubMed ID: 28559437)
1. Fibroblast growth factor 21: a regulator of metabolic disease and health span.
Xie T; Leung PS
Am J Physiol Endocrinol Metab; 2017 Sep; 313(3):E292-E302. PubMed ID: 28559437
[TBL] [Abstract][Full Text] [Related]
2. Association between insulin resistance and impairment of FGF21 signal transduction in skeletal muscles.
Jeon JY; Choi SE; Ha ES; Kim TH; Jung JG; Han SJ; Kim HJ; Kim DJ; Kang Y; Lee KW
Endocrine; 2016 Jul; 53(1):97-106. PubMed ID: 26758997
[TBL] [Abstract][Full Text] [Related]
3. Potential roles of fibroblast growth factor 21 in the brain.
Sa-Nguanmoo P; Chattipakorn N; Chattipakorn SC
Metab Brain Dis; 2016 Apr; 31(2):239-48. PubMed ID: 26738728
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast Growth Factor 21 As an Emerging Therapeutic Target for Type 2 Diabetes Mellitus.
So WY; Leung PS
Med Res Rev; 2016 Jul; 36(4):672-704. PubMed ID: 27031294
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor 21: a novel metabolic regulator with potential therapeutic properties in obesity/type 2 diabetes mellitus.
Dostálová I; Haluzíková D; Haluzík M
Physiol Res; 2009; 58(1):1-7. PubMed ID: 19331512
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor-21, energy balance and obesity.
Giralt M; Gavaldà-Navarro A; Villarroya F
Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():66-73. PubMed ID: 26415590
[TBL] [Abstract][Full Text] [Related]
7. βKlotho is required for fibroblast growth factor 21 effects on growth and metabolism.
Ding X; Boney-Montoya J; Owen BM; Bookout AL; Coate KC; Mangelsdorf DJ; Kliewer SA
Cell Metab; 2012 Sep; 16(3):387-93. PubMed ID: 22958921
[TBL] [Abstract][Full Text] [Related]
8. Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21.
Iglesias P; Selgas R; Romero S; Díez JJ
Eur J Endocrinol; 2012 Sep; 167(3):301-9. PubMed ID: 22740503
[TBL] [Abstract][Full Text] [Related]
9. FGF21 in obesity and cancer: New insights.
Lu W; Li X; Luo Y
Cancer Lett; 2021 Feb; 499():5-13. PubMed ID: 33264641
[TBL] [Abstract][Full Text] [Related]
10. Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients.
Gallego-Escuredo JM; Gómez-Ambrosi J; Catalan V; Domingo P; Giralt M; Frühbeck G; Villarroya F
Int J Obes (Lond); 2015 Jan; 39(1):121-9. PubMed ID: 24813368
[TBL] [Abstract][Full Text] [Related]
11. Impact of FGF21 on glycemic control.
Strowski MZ
Horm Mol Biol Clin Investig; 2017 Jun; 30(2):. PubMed ID: 28593912
[TBL] [Abstract][Full Text] [Related]
12. Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice.
Lin Z; Tian H; Lam KS; Lin S; Hoo RC; Konishi M; Itoh N; Wang Y; Bornstein SR; Xu A; Li X
Cell Metab; 2013 May; 17(5):779-89. PubMed ID: 23663741
[TBL] [Abstract][Full Text] [Related]
13. Tissue-specific actions of the metabolic hormones FGF15/19 and FGF21.
Owen BM; Mangelsdorf DJ; Kliewer SA
Trends Endocrinol Metab; 2015 Jan; 26(1):22-9. PubMed ID: 25476453
[TBL] [Abstract][Full Text] [Related]
14. Effects of insulin and exercise training on FGF21, its receptors and target genes in obesity and type 2 diabetes.
Kruse R; Vienberg SG; Vind BF; Andersen B; Højlund K
Diabetologia; 2017 Oct; 60(10):2042-2051. PubMed ID: 28721439
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast Growth Factor 21 and the Adaptive Response to Nutritional Challenges.
Martínez-Garza Ú; Torres-Oteros D; Yarritu-Gallego A; Marrero PF; Haro D; Relat J
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31546675
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of β-Klotho in Adipose Tissue Sensitizes Male Mice to Endogenous FGF21 and Provides Protection From Diet-Induced Obesity.
Samms RJ; Cheng CC; Kharitonenkov A; Gimeno RE; Adams AC
Endocrinology; 2016 Apr; 157(4):1467-80. PubMed ID: 26901091
[TBL] [Abstract][Full Text] [Related]
17. A Novel Fc-FGF21 With Improved Resistance to Proteolysis, Increased Affinity Toward β-Klotho, and Enhanced Efficacy in Mice and Cynomolgus Monkeys.
Stanislaus S; Hecht R; Yie J; Hager T; Hall M; Spahr C; Wang W; Weiszmann J; Li Y; Deng L; Winters D; Smith S; Zhou L; Li Y; Véniant MM; Xu J
Endocrinology; 2017 May; 158(5):1314-1327. PubMed ID: 28324011
[TBL] [Abstract][Full Text] [Related]
18. Beta-klotho in type 2 diabetes mellitus: From pathophysiology to therapeutic strategies.
Hua S; Liu Q; Li J; Fan M; Yan K; Ye D
Rev Endocr Metab Disord; 2021 Dec; 22(4):1091-1109. PubMed ID: 34120289
[TBL] [Abstract][Full Text] [Related]
19. The Role and Potential Therapeutic Implications of the Fibroblast Growth Factors in Energy Balance and Type 2 Diabetes.
Izaguirre M; Gil MJ; Monreal I; Montecucco F; Frühbeck G; Catalán V
Curr Diab Rep; 2017 Jun; 17(6):43. PubMed ID: 28451950
[TBL] [Abstract][Full Text] [Related]
20. Role of fibroblast growth factor 21 in gestational diabetes mellitus: A mini-review.
Yuan D; Wu BJ; Henry A; Rye KA; Ong KL
Clin Endocrinol (Oxf); 2019 Jan; 90(1):47-55. PubMed ID: 30346647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
